White Paper

A Molecule's Journey: Break Down Roadblocks To Commercial Manufacturing Success

By Christian Cattaruzza, Steven Strubbe, Laure Valognes, Corinne Lavie-Cambot, Laetitia Botrel, and Muriel Richard, BioReliance® End-to-End Solution

Laboratory bioprocess iStock-1144377258

Selection and implementation of a commercial manufacturing strategy that will ensure long term success is among the most critical decisions a biopharmaceutical company will make.

Every drug is unique and there are many options and factors to consider when it comes to identifying the best approach to commercial GMP manufacturing. The right strategy must align with your organizational objectives and be cost-effective, deliver the necessary quantity of drug substance, reduce risk and meet regulatory expectations. In this guidebook, our experts share key considerations for biopharmaceutical companies as they advance to commercial manufacturing and navigate complexities associated with business planning, process scale-up, optimization and validation, technology considerations and regulatory compliance.

access the White Paper!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.

Subscribe to Outsourced Pharma X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Outsourced Pharma